Possibly, due to the immaturity of intestinal CYP3A, as we showed earlier in our midazolam pharmacokinetic studies, this difference did not reach statistical significance[ 17 ].
1
—
—
Possibly, due to the immaturity of intestinal CYP3A, as we showed earlier in our midazolam pharmacokinetic studies, this difference did not reach statistical significance[ 17 ].